"004.009" . . . . . "P\u0159\u00EDznaky p\u0159ed\u00E1vkov\u00E1n\u00ED\nP\u0159ed\u00E1vkov\u00E1n\u00ED m\u016F\u017Ee vyvolat t\u011B\u017Ekou hypotenzi, srde\u010Dn\u00ED insuficienci, kardiogenn\u00ED \u0161ok, bradykardii a\u017E z\u00E1stavu srdce. D\u00E1le se mohou objevit d\u00FDchac\u00ED pot\u00ED\u017Ee, bronchospazmus, zvracen\u00ED, porucha v\u011Bdom\u00ED a tak\u00E9 generalizovan\u00E9 k\u0159e\u010De.\nTerapeutick\u00E1 opat\u0159en\u00ED p\u0159i p\u0159ed\u00E1vkov\u00E1n\u00ED\nKrom\u011B v\u0161eobecn\u00FDch opat\u0159en\u00ED je t\u0159eba na jednotce intenzivn\u00ED p\u00E9\u010De monitorovat a podle pot\u0159eby upravovat \u017Eivotn\u011B d\u016Fle\u017Eit\u00E9 funkce.\nDaj\u00ED se pou\u017E\u00EDt tato antidota:\n- atropin:\n0,5 - 0,2 mg jako intraven\u00F3zn\u00ED bolus.\n- glukagon:\nzpo\u010D\u00E1tku 1 a\u017E 10 mg intraven\u00F3zn\u011B, pak 2 a\u017E 2,5 mg/h v dlouhodob\u00E9 infuzi.\n- beta-sympatomimetika d\u00E1vkovan\u00E1 v z\u00E1vislosti na t\u011Blesn\u00E9 hmotnosti a na dosa\u017Een\u00E9m \u00FA\u010Dinku: dobutamin, isoprenalin, orciprenalin nebo adrenalin.\nP\u0159i bradykardii, nereaguj\u00EDc\u00ED na farmakoterapii, je t\u0159eba uva\u017Eovat o zaveden\u00ED pacemakeru.\nBeta2-sympatomimetika (v aerosolu anebo, nen\u00ED-li \u00FA\u010Dinek dostate\u010Dn\u00FD, intraven\u00F3zn\u011B) anebo aminofylin se mohou podat k l\u00E9\u010Db\u011B bronchospazm\u016F.\nPomal\u00E1 intraven\u00F3zn\u00ED injekce diazepamu se doporu\u010Duje p\u0159i k\u0159e\u010D\u00EDch.\n"@cs . . . . . "4.9 P\u0159ed\u00E1vkov\u00E1n\u00ED"@cs .